June 21, 2024 10:12 AM EDT
News Briefing

Lay­offs at Gink­go and Xel­lia; Melo­dia and Alivex­is ink $275M part­ner­ship

Ayisha Sharma

News Reporter

Plus, news about Ra­pa­fusyn Phar­ma­ceu­ti­cals:

Gink­go Bioworks lays off 158 em­ploy­ees: The cuts come af­ter the Boston, MA-based biotech said last month …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck pays $30M to buy ‘chameleon’ ap­proach to dead­ly brain can­cers

Eye drop mak­er to merge with a reti­nal gene ther­a­py start­up from Spark co-founder

UK’s price watch­dog says Lil­ly’s Alzheimer’s drug is too cost­ly for broad up­take

Cor­rect­ed: Sang­amo to seek ac­cel­er­at­ed ap­proval for Fab­ry gene ther­a­py, claims it won't need con­fir­ma­to­ry study

Am­gen preps to launch Eylea biosim­i­lar years ear­ly af­ter Re­gen­eron los­es ap­peal

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times